DEPIPZO Trademark

Trademark Overview

On Monday, April 30, 2018, a trademark application was filed for DEPIPZO with the United States Patent and Trademark Office. The USPTO has given the DEPIPZO trademark a serial number of 87900863. The federal status of this trademark filing is REGISTERED as of Tuesday, June 18, 2019. This trademark is owned by CMG Pharmaceutical Co.,Ltd.. The DEPIPZO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and veterinary preparations for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; sanitary preparations for medical purposes; biotechnological preparations for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; biological preparations for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogen...
depipzo

General Information

Serial Number87900863
Word MarkDEPIPZO
Filing DateMonday, April 30, 2018
Status700 - REGISTERED
Status DateTuesday, June 18, 2019
Registration Number5779008
Registration DateTuesday, June 18, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 2, 2019

Trademark Statements

Goods and ServicesPharmaceutical and veterinary preparations for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; sanitary preparations for medical purposes; biotechnological preparations for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; biological preparations for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; drugs for medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; pharmaceuticals for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; multivitamins preparations; pharmaceutical preparations for diagnosis for medical or veterinary purposes; nutraceutical preparations for therapeutic or medical purposes for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics; preparations of microorganisms for medical and veterinary use for the treatment of cardiovascular disease, central nervous system disease and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious disease, auto-immune disease, antibiotics

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 9, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCMG Pharmaceutical Co.,Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGangnam-gu, Seoul
KR
Party NameCMG Pharmaceutical Co.,Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGangnam-gu, Seoul
KR
Party NameCMG Pharmaceutical Co.,Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGangnam-gu, Seoul
KR

Trademark Events

Event DateEvent Description
Tuesday, August 21, 2018NON-FINAL ACTION WRITTEN
Thursday, May 3, 2018NEW APPLICATION ENTERED
Wednesday, May 9, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 21, 2018ASSIGNED TO EXAMINER
Tuesday, August 21, 2018NON-FINAL ACTION E-MAILED
Tuesday, August 21, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 7, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 13, 2019ASSIGNED TO LIE
Tuesday, February 19, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 19, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 20, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 22, 2019ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, February 26, 2019ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, March 13, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 2, 2019PUBLISHED FOR OPPOSITION
Tuesday, April 2, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 18, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, June 18, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

depipzo disorders disease preparations neurological purposes urological medical system nervous treatment